Medical Care
Antifungal infection Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 548378
- Pages: 127
- Figures: 219
- Views: 3
Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.
The global market for Antifungal infection Therapeutics was estimated to be worth US$ 18650 million in 2023 and is forecast to a readjusted size of US$ 29440 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antifungal infection Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antifungal infection Therapeutics by region & country, by Type, and by Application.
The Antifungal infection Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal infection Therapeutics.
Market Segmentation
By Company
Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories
Segment by Type:
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types
Segment by Application
Hospitals and Clinics
Dermatology Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antifungal infection Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antifungal infection Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antifungal infection Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Antifungal infection Therapeutics was estimated to be worth US$ 18650 million in 2023 and is forecast to a readjusted size of US$ 29440 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antifungal infection Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antifungal infection Therapeutics by region & country, by Type, and by Application.
The Antifungal infection Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal infection Therapeutics.
Market Segmentation
By Company
Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories
Segment by Type:
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types
Segment by Application
Hospitals and Clinics
Dermatology Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antifungal infection Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antifungal infection Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antifungal infection Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Antifungal infection Therapeutics Product Introduction
1.2 Global Antifungal infection Therapeutics Market Size Forecast
1.3 Antifungal infection Therapeutics Market Trends & Drivers
1.3.1 Antifungal infection Therapeutics Industry Trends
1.3.2 Antifungal infection Therapeutics Market Drivers & Opportunity
1.3.3 Antifungal infection Therapeutics Market Challenges
1.3.4 Antifungal infection Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antifungal infection Therapeutics Players Revenue Ranking (2023)
2.2 Global Antifungal infection Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Antifungal infection Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antifungal infection Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Antifungal infection Therapeutics
2.6 Antifungal infection Therapeutics Market Competitive Analysis
2.6.1 Antifungal infection Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antifungal infection Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polyenes
3.1.2 Echinocandins
3.1.3 Azoles
3.1.4 Allylamines
3.1.5 Other Drug types
3.2 Global Antifungal infection Therapeutics Sales Value by Type
3.2.1 Global Antifungal infection Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antifungal infection Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Antifungal infection Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Dermatology Clinic
4.2 Global Antifungal infection Therapeutics Sales Value by Application
4.2.1 Global Antifungal infection Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antifungal infection Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Antifungal infection Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antifungal infection Therapeutics Sales Value by Region
5.1.1 Global Antifungal infection Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antifungal infection Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Antifungal infection Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Antifungal infection Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antifungal infection Therapeutics Sales Value, 2019-2030
5.2.2 North America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antifungal infection Therapeutics Sales Value, 2019-2030
5.3.2 Europe Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antifungal infection Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antifungal infection Therapeutics Sales Value, 2019-2030
5.5.2 South America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antifungal infection Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antifungal infection Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antifungal infection Therapeutics Sales Value
6.3 United States
6.3.1 United States Antifungal infection Therapeutics Sales Value, 2019-2030
6.3.2 United States Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antifungal infection Therapeutics Sales Value, 2019-2030
6.4.2 Europe Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antifungal infection Therapeutics Sales Value, 2019-2030
6.5.2 China Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antifungal infection Therapeutics Sales Value, 2019-2030
6.6.2 Japan Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antifungal infection Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antifungal infection Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antifungal infection Therapeutics Sales Value, 2019-2030
6.9.2 India Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Scynexis
7.1.1 Scynexis Profile
7.1.2 Scynexis Main Business
7.1.3 Scynexis Antifungal infection Therapeutics Products, Services and Solutions
7.1.4 Scynexis Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Scynexis Recent Developments
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Profile
7.2.2 Sanofi-Aventis Main Business
7.2.3 Sanofi-Aventis Antifungal infection Therapeutics Products, Services and Solutions
7.2.4 Sanofi-Aventis Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Sanofi-Aventis Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Antifungal infection Therapeutics Products, Services and Solutions
7.3.4 Pfizer Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Novartis Recent Developments
7.4 Novartis
7.4.1 Novartis Profile
7.4.2 Novartis Main Business
7.4.3 Novartis Antifungal infection Therapeutics Products, Services and Solutions
7.4.4 Novartis Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Novartis Recent Developments
7.5 Merck & Co
7.5.1 Merck & Co Profile
7.5.2 Merck & Co Main Business
7.5.3 Merck & Co Antifungal infection Therapeutics Products, Services and Solutions
7.5.4 Merck & Co Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Merck & Co Recent Developments
7.6 Kramer Laboratories
7.6.1 Kramer Laboratories Profile
7.6.2 Kramer Laboratories Main Business
7.6.3 Kramer Laboratories Antifungal infection Therapeutics Products, Services and Solutions
7.6.4 Kramer Laboratories Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Kramer Laboratories Recent Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Profile
7.7.2 Johnson & Johnson Main Business
7.7.3 Johnson & Johnson Antifungal infection Therapeutics Products, Services and Solutions
7.7.4 Johnson & Johnson Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Johnson & Johnson Recent Developments
7.8 ID Sigma-Aldrich Corporation
7.8.1 ID Sigma-Aldrich Corporation Profile
7.8.2 ID Sigma-Aldrich Corporation Main Business
7.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Products, Services and Solutions
7.8.4 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 ID Sigma-Aldrich Corporation Recent Developments
7.9 Glenmark Pharmaceuticals
7.9.1 Glenmark Pharmaceuticals Profile
7.9.2 Glenmark Pharmaceuticals Main Business
7.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
7.9.4 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Glenmark Pharmaceuticals Recent Developments
7.10 Glaxosmithkline
7.10.1 Glaxosmithkline Profile
7.10.2 Glaxosmithkline Main Business
7.10.3 Glaxosmithkline Antifungal infection Therapeutics Products, Services and Solutions
7.10.4 Glaxosmithkline Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Glaxosmithkline Recent Developments
7.11 Enzon Pharmaceuticals
7.11.1 Enzon Pharmaceuticals Profile
7.11.2 Enzon Pharmaceuticals Main Business
7.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
7.11.4 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Enzon Pharmaceuticals Recent Developments
7.12 Bayer Healthcare
7.12.1 Bayer Healthcare Profile
7.12.2 Bayer Healthcare Main Business
7.12.3 Bayer Healthcare Antifungal infection Therapeutics Products, Services and Solutions
7.12.4 Bayer Healthcare Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Bayer Healthcare Recent Developments
7.13 Astellas Pharma
7.13.1 Astellas Pharma Profile
7.13.2 Astellas Pharma Main Business
7.13.3 Astellas Pharma Antifungal infection Therapeutics Products, Services and Solutions
7.13.4 Astellas Pharma Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Astellas Pharma Recent Developments
7.14 Asperqillus
7.14.1 Asperqillus Profile
7.14.2 Asperqillus Main Business
7.14.3 Asperqillus Antifungal infection Therapeutics Products, Services and Solutions
7.14.4 Asperqillus Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Asperqillus Recent Developments
7.15 Alternaria
7.15.1 Alternaria Profile
7.15.2 Alternaria Main Business
7.15.3 Alternaria Antifungal infection Therapeutics Products, Services and Solutions
7.15.4 Alternaria Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Alternaria Recent Developments
7.16 Abbott Laboratories
7.16.1 Abbott Laboratories Profile
7.16.2 Abbott Laboratories Main Business
7.16.3 Abbott Laboratories Antifungal infection Therapeutics Products, Services and Solutions
7.16.4 Abbott Laboratories Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Abbott Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Antifungal infection Therapeutics Industrial Chain
8.2 Antifungal infection Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antifungal infection Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Antifungal infection Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Antifungal infection Therapeutics Product Introduction
1.2 Global Antifungal infection Therapeutics Market Size Forecast
1.3 Antifungal infection Therapeutics Market Trends & Drivers
1.3.1 Antifungal infection Therapeutics Industry Trends
1.3.2 Antifungal infection Therapeutics Market Drivers & Opportunity
1.3.3 Antifungal infection Therapeutics Market Challenges
1.3.4 Antifungal infection Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antifungal infection Therapeutics Players Revenue Ranking (2023)
2.2 Global Antifungal infection Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Antifungal infection Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antifungal infection Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Antifungal infection Therapeutics
2.6 Antifungal infection Therapeutics Market Competitive Analysis
2.6.1 Antifungal infection Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antifungal infection Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polyenes
3.1.2 Echinocandins
3.1.3 Azoles
3.1.4 Allylamines
3.1.5 Other Drug types
3.2 Global Antifungal infection Therapeutics Sales Value by Type
3.2.1 Global Antifungal infection Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antifungal infection Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Antifungal infection Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Dermatology Clinic
4.2 Global Antifungal infection Therapeutics Sales Value by Application
4.2.1 Global Antifungal infection Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antifungal infection Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Antifungal infection Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antifungal infection Therapeutics Sales Value by Region
5.1.1 Global Antifungal infection Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antifungal infection Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Antifungal infection Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Antifungal infection Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antifungal infection Therapeutics Sales Value, 2019-2030
5.2.2 North America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antifungal infection Therapeutics Sales Value, 2019-2030
5.3.2 Europe Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antifungal infection Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antifungal infection Therapeutics Sales Value, 2019-2030
5.5.2 South America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antifungal infection Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antifungal infection Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antifungal infection Therapeutics Sales Value
6.3 United States
6.3.1 United States Antifungal infection Therapeutics Sales Value, 2019-2030
6.3.2 United States Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antifungal infection Therapeutics Sales Value, 2019-2030
6.4.2 Europe Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antifungal infection Therapeutics Sales Value, 2019-2030
6.5.2 China Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antifungal infection Therapeutics Sales Value, 2019-2030
6.6.2 Japan Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antifungal infection Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antifungal infection Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antifungal infection Therapeutics Sales Value, 2019-2030
6.9.2 India Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antifungal infection Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Scynexis
7.1.1 Scynexis Profile
7.1.2 Scynexis Main Business
7.1.3 Scynexis Antifungal infection Therapeutics Products, Services and Solutions
7.1.4 Scynexis Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Scynexis Recent Developments
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Profile
7.2.2 Sanofi-Aventis Main Business
7.2.3 Sanofi-Aventis Antifungal infection Therapeutics Products, Services and Solutions
7.2.4 Sanofi-Aventis Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Sanofi-Aventis Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Antifungal infection Therapeutics Products, Services and Solutions
7.3.4 Pfizer Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Novartis Recent Developments
7.4 Novartis
7.4.1 Novartis Profile
7.4.2 Novartis Main Business
7.4.3 Novartis Antifungal infection Therapeutics Products, Services and Solutions
7.4.4 Novartis Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Novartis Recent Developments
7.5 Merck & Co
7.5.1 Merck & Co Profile
7.5.2 Merck & Co Main Business
7.5.3 Merck & Co Antifungal infection Therapeutics Products, Services and Solutions
7.5.4 Merck & Co Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Merck & Co Recent Developments
7.6 Kramer Laboratories
7.6.1 Kramer Laboratories Profile
7.6.2 Kramer Laboratories Main Business
7.6.3 Kramer Laboratories Antifungal infection Therapeutics Products, Services and Solutions
7.6.4 Kramer Laboratories Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Kramer Laboratories Recent Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Profile
7.7.2 Johnson & Johnson Main Business
7.7.3 Johnson & Johnson Antifungal infection Therapeutics Products, Services and Solutions
7.7.4 Johnson & Johnson Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Johnson & Johnson Recent Developments
7.8 ID Sigma-Aldrich Corporation
7.8.1 ID Sigma-Aldrich Corporation Profile
7.8.2 ID Sigma-Aldrich Corporation Main Business
7.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Products, Services and Solutions
7.8.4 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 ID Sigma-Aldrich Corporation Recent Developments
7.9 Glenmark Pharmaceuticals
7.9.1 Glenmark Pharmaceuticals Profile
7.9.2 Glenmark Pharmaceuticals Main Business
7.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
7.9.4 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Glenmark Pharmaceuticals Recent Developments
7.10 Glaxosmithkline
7.10.1 Glaxosmithkline Profile
7.10.2 Glaxosmithkline Main Business
7.10.3 Glaxosmithkline Antifungal infection Therapeutics Products, Services and Solutions
7.10.4 Glaxosmithkline Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Glaxosmithkline Recent Developments
7.11 Enzon Pharmaceuticals
7.11.1 Enzon Pharmaceuticals Profile
7.11.2 Enzon Pharmaceuticals Main Business
7.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
7.11.4 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Enzon Pharmaceuticals Recent Developments
7.12 Bayer Healthcare
7.12.1 Bayer Healthcare Profile
7.12.2 Bayer Healthcare Main Business
7.12.3 Bayer Healthcare Antifungal infection Therapeutics Products, Services and Solutions
7.12.4 Bayer Healthcare Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Bayer Healthcare Recent Developments
7.13 Astellas Pharma
7.13.1 Astellas Pharma Profile
7.13.2 Astellas Pharma Main Business
7.13.3 Astellas Pharma Antifungal infection Therapeutics Products, Services and Solutions
7.13.4 Astellas Pharma Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Astellas Pharma Recent Developments
7.14 Asperqillus
7.14.1 Asperqillus Profile
7.14.2 Asperqillus Main Business
7.14.3 Asperqillus Antifungal infection Therapeutics Products, Services and Solutions
7.14.4 Asperqillus Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Asperqillus Recent Developments
7.15 Alternaria
7.15.1 Alternaria Profile
7.15.2 Alternaria Main Business
7.15.3 Alternaria Antifungal infection Therapeutics Products, Services and Solutions
7.15.4 Alternaria Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Alternaria Recent Developments
7.16 Abbott Laboratories
7.16.1 Abbott Laboratories Profile
7.16.2 Abbott Laboratories Main Business
7.16.3 Abbott Laboratories Antifungal infection Therapeutics Products, Services and Solutions
7.16.4 Abbott Laboratories Antifungal infection Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Abbott Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Antifungal infection Therapeutics Industrial Chain
8.2 Antifungal infection Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antifungal infection Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Antifungal infection Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Antifungal infection Therapeutics Market Trends
Table 2. Antifungal infection Therapeutics Market Drivers & Opportunity
Table 3. Antifungal infection Therapeutics Market Challenges
Table 4. Antifungal infection Therapeutics Market Restraints
Table 5. Global Antifungal infection Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antifungal infection Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antifungal infection Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antifungal infection Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Antifungal infection Therapeutics
Table 10. Global Antifungal infection Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antifungal infection Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antifungal infection Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antifungal infection Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antifungal infection Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antifungal infection Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antifungal infection Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antifungal infection Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antifungal infection Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antifungal infection Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antifungal infection Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antifungal infection Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antifungal infection Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antifungal infection Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antifungal infection Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Antifungal infection Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antifungal infection Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antifungal infection Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antifungal infection Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Scynexis Basic Information List
Table 32. Scynexis Description and Business Overview
Table 33. Scynexis Antifungal infection Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Scynexis (2019-2024)
Table 35. Scynexis Recent Developments
Table 36. Sanofi-Aventis Basic Information List
Table 37. Sanofi-Aventis Description and Business Overview
Table 38. Sanofi-Aventis Antifungal infection Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Sanofi-Aventis (2019-2024)
Table 40. Sanofi-Aventis Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Antifungal infection Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Antifungal infection Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Merck & Co Basic Information List
Table 52. Merck & Co Description and Business Overview
Table 53. Merck & Co Antifungal infection Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Merck & Co (2019-2024)
Table 55. Merck & Co Recent Developments
Table 56. Kramer Laboratories Basic Information List
Table 57. Kramer Laboratories Description and Business Overview
Table 58. Kramer Laboratories Antifungal infection Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Kramer Laboratories (2019-2024)
Table 60. Kramer Laboratories Recent Developments
Table 61. Johnson & Johnson Basic Information List
Table 62. Johnson & Johnson Description and Business Overview
Table 63. Johnson & Johnson Antifungal infection Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Johnson & Johnson (2019-2024)
Table 65. Johnson & Johnson Recent Developments
Table 66. ID Sigma-Aldrich Corporation Basic Information List
Table 67. ID Sigma-Aldrich Corporation Description and Business Overview
Table 68. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antifungal infection Therapeutics Business of ID Sigma-Aldrich Corporation (2019-2024)
Table 70. ID Sigma-Aldrich Corporation Recent Developments
Table 71. Glenmark Pharmaceuticals Basic Information List
Table 72. Glenmark Pharmaceuticals Description and Business Overview
Table 73. Glenmark Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Glenmark Pharmaceuticals (2019-2024)
Table 75. Glenmark Pharmaceuticals Recent Developments
Table 76. Glaxosmithkline Basic Information List
Table 77. Glaxosmithkline Description and Business Overview
Table 78. Glaxosmithkline Antifungal infection Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Glaxosmithkline (2019-2024)
Table 80. Glaxosmithkline Recent Developments
Table 81. Enzon Pharmaceuticals Basic Information List
Table 82. Enzon Pharmaceuticals Description and Business Overview
Table 83. Enzon Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Enzon Pharmaceuticals (2019-2024)
Table 85. Enzon Pharmaceuticals Recent Developments
Table 86. Bayer Healthcare Basic Information List
Table 87. Bayer Healthcare Description and Business Overview
Table 88. Bayer Healthcare Antifungal infection Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Bayer Healthcare (2019-2024)
Table 90. Bayer Healthcare Recent Developments
Table 91. Astellas Pharma Basic Information List
Table 92. Astellas Pharma Description and Business Overview
Table 93. Astellas Pharma Antifungal infection Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Astellas Pharma (2019-2024)
Table 95. Astellas Pharma Recent Developments
Table 96. Asperqillus Basic Information List
Table 97. Asperqillus Description and Business Overview
Table 98. Asperqillus Antifungal infection Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Asperqillus (2019-2024)
Table 100. Asperqillus Recent Developments
Table 101. Alternaria Basic Information List
Table 102. Alternaria Description and Business Overview
Table 103. Alternaria Antifungal infection Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Alternaria (2019-2024)
Table 105. Alternaria Recent Developments
Table 106. Abbott Laboratories Basic Information List
Table 107. Abbott Laboratories Description and Business Overview
Table 108. Abbott Laboratories Antifungal infection Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Abbott Laboratories (2019-2024)
Table 110. Abbott Laboratories Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Antifungal infection Therapeutics Downstream Customers
Table 114. Antifungal infection Therapeutics Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antifungal infection Therapeutics Product Picture
Figure 2. Global Antifungal infection Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Antifungal infection Therapeutics Report Years Considered
Figure 5. Global Antifungal infection Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antifungal infection Therapeutics Revenue in 2023
Figure 7. Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Polyenes Picture
Figure 9. Echinocandins Picture
Figure 10. Azoles Picture
Figure 11. Allylamines Picture
Figure 12. Other Drug types Picture
Figure 13. Global Antifungal infection Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Antifungal infection Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals and Clinics
Figure 16. Product Picture of Dermatology Clinic
Figure 17. Global Antifungal infection Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Antifungal infection Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Antifungal infection Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Antifungal infection Therapeutics Industrial Chain
Figure 52. Antifungal infection Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Antifungal infection Therapeutics Market Trends
Table 2. Antifungal infection Therapeutics Market Drivers & Opportunity
Table 3. Antifungal infection Therapeutics Market Challenges
Table 4. Antifungal infection Therapeutics Market Restraints
Table 5. Global Antifungal infection Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antifungal infection Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antifungal infection Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antifungal infection Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Antifungal infection Therapeutics
Table 10. Global Antifungal infection Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antifungal infection Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antifungal infection Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antifungal infection Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antifungal infection Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antifungal infection Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antifungal infection Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antifungal infection Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antifungal infection Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antifungal infection Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antifungal infection Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antifungal infection Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antifungal infection Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antifungal infection Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antifungal infection Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Antifungal infection Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antifungal infection Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antifungal infection Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antifungal infection Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Scynexis Basic Information List
Table 32. Scynexis Description and Business Overview
Table 33. Scynexis Antifungal infection Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Scynexis (2019-2024)
Table 35. Scynexis Recent Developments
Table 36. Sanofi-Aventis Basic Information List
Table 37. Sanofi-Aventis Description and Business Overview
Table 38. Sanofi-Aventis Antifungal infection Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Sanofi-Aventis (2019-2024)
Table 40. Sanofi-Aventis Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Antifungal infection Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Antifungal infection Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Merck & Co Basic Information List
Table 52. Merck & Co Description and Business Overview
Table 53. Merck & Co Antifungal infection Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Merck & Co (2019-2024)
Table 55. Merck & Co Recent Developments
Table 56. Kramer Laboratories Basic Information List
Table 57. Kramer Laboratories Description and Business Overview
Table 58. Kramer Laboratories Antifungal infection Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Kramer Laboratories (2019-2024)
Table 60. Kramer Laboratories Recent Developments
Table 61. Johnson & Johnson Basic Information List
Table 62. Johnson & Johnson Description and Business Overview
Table 63. Johnson & Johnson Antifungal infection Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Johnson & Johnson (2019-2024)
Table 65. Johnson & Johnson Recent Developments
Table 66. ID Sigma-Aldrich Corporation Basic Information List
Table 67. ID Sigma-Aldrich Corporation Description and Business Overview
Table 68. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antifungal infection Therapeutics Business of ID Sigma-Aldrich Corporation (2019-2024)
Table 70. ID Sigma-Aldrich Corporation Recent Developments
Table 71. Glenmark Pharmaceuticals Basic Information List
Table 72. Glenmark Pharmaceuticals Description and Business Overview
Table 73. Glenmark Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Glenmark Pharmaceuticals (2019-2024)
Table 75. Glenmark Pharmaceuticals Recent Developments
Table 76. Glaxosmithkline Basic Information List
Table 77. Glaxosmithkline Description and Business Overview
Table 78. Glaxosmithkline Antifungal infection Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Glaxosmithkline (2019-2024)
Table 80. Glaxosmithkline Recent Developments
Table 81. Enzon Pharmaceuticals Basic Information List
Table 82. Enzon Pharmaceuticals Description and Business Overview
Table 83. Enzon Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Enzon Pharmaceuticals (2019-2024)
Table 85. Enzon Pharmaceuticals Recent Developments
Table 86. Bayer Healthcare Basic Information List
Table 87. Bayer Healthcare Description and Business Overview
Table 88. Bayer Healthcare Antifungal infection Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Bayer Healthcare (2019-2024)
Table 90. Bayer Healthcare Recent Developments
Table 91. Astellas Pharma Basic Information List
Table 92. Astellas Pharma Description and Business Overview
Table 93. Astellas Pharma Antifungal infection Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Astellas Pharma (2019-2024)
Table 95. Astellas Pharma Recent Developments
Table 96. Asperqillus Basic Information List
Table 97. Asperqillus Description and Business Overview
Table 98. Asperqillus Antifungal infection Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Asperqillus (2019-2024)
Table 100. Asperqillus Recent Developments
Table 101. Alternaria Basic Information List
Table 102. Alternaria Description and Business Overview
Table 103. Alternaria Antifungal infection Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Alternaria (2019-2024)
Table 105. Alternaria Recent Developments
Table 106. Abbott Laboratories Basic Information List
Table 107. Abbott Laboratories Description and Business Overview
Table 108. Abbott Laboratories Antifungal infection Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Abbott Laboratories (2019-2024)
Table 110. Abbott Laboratories Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Antifungal infection Therapeutics Downstream Customers
Table 114. Antifungal infection Therapeutics Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antifungal infection Therapeutics Product Picture
Figure 2. Global Antifungal infection Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Antifungal infection Therapeutics Report Years Considered
Figure 5. Global Antifungal infection Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antifungal infection Therapeutics Revenue in 2023
Figure 7. Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Polyenes Picture
Figure 9. Echinocandins Picture
Figure 10. Azoles Picture
Figure 11. Allylamines Picture
Figure 12. Other Drug types Picture
Figure 13. Global Antifungal infection Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Antifungal infection Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals and Clinics
Figure 16. Product Picture of Dermatology Clinic
Figure 17. Global Antifungal infection Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Antifungal infection Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Antifungal infection Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Antifungal infection Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Antifungal infection Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Antifungal infection Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Antifungal infection Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Antifungal infection Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Antifungal infection Therapeutics Industrial Chain
Figure 52. Antifungal infection Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232